Autoinflammatory diseases and the kidney
AbstractThe kidney represents an important target of systemic inflammation. Its involvement in monogenic and multifactorial autoinflammatory diseases (AIDs) vary from peculiar and relatively frequent manifestations to some rare but severe features that may end up requiring transplantation. The pathogenetic background is also very heterogeneous ranging from amyloidosis to non-amyloid related damage rooted in inflammasome activation. Kidney involvement in monogenic and polygenic AIDs may present as renal amyloidosis, IgA nephropathy, and more rarely as various forms of glomerulonephritis (GN), namely segmental glomeruloscler...
Source: Immunologic Research - March 29, 2023 Category: Allergy & Immunology Source Type: research
Baricitinib for the treatment of refractory vascular Beh çet's disease
CONCLUSIONS: Our study suggests that baricitinib is well-tolerated and effective in treating refractory vascular/cardiac BD patients.PMID:36967024 | DOI:10.1016/j.clim.2023.109298 (Source: Clinical Immunology)
Source: Clinical Immunology - March 26, 2023 Category: Allergy & Immunology Authors: Zhimian Wang Xiaoou Wang Weiwei Liu Yuhua Wang Jinjing Liu Li Zhang Shangzhu Zhang Xinping Tian Yan Zhao Wenjie Zheng Source Type: research
Baricitinib for the treatment of refractory vascular Beh çet's disease
CONCLUSIONS: Our study suggests that baricitinib is well-tolerated and effective in treating refractory vascular/cardiac BD patients.PMID:36967024 | DOI:10.1016/j.clim.2023.109298 (Source: Clinical Immunology)
Source: Clinical Immunology - March 26, 2023 Category: Allergy & Immunology Authors: Zhimian Wang Xiaoou Wang Weiwei Liu Yuhua Wang Jinjing Liu Li Zhang Shangzhu Zhang Xinping Tian Yan Zhao Wenjie Zheng Source Type: research
Baricitinib for the treatment of refractory vascular Beh çet's disease
CONCLUSIONS: Our study suggests that baricitinib is well-tolerated and effective in treating refractory vascular/cardiac BD patients.PMID:36967024 | DOI:10.1016/j.clim.2023.109298 (Source: Clinical Immunology)
Source: Clinical Immunology - March 26, 2023 Category: Allergy & Immunology Authors: Zhimian Wang Xiaoou Wang Weiwei Liu Yuhua Wang Jinjing Liu Li Zhang Shangzhu Zhang Xinping Tian Yan Zhao Wenjie Zheng Source Type: research
Baricitinib for the treatment of refractory vascular Beh çet's disease
CONCLUSIONS: Our study suggests that baricitinib is well-tolerated and effective in treating refractory vascular/cardiac BD patients.PMID:36967024 | DOI:10.1016/j.clim.2023.109298 (Source: Clinical Immunology)
Source: Clinical Immunology - March 26, 2023 Category: Allergy & Immunology Authors: Zhimian Wang Xiaoou Wang Weiwei Liu Yuhua Wang Jinjing Liu Li Zhang Shangzhu Zhang Xinping Tian Yan Zhao Wenjie Zheng Source Type: research
A Rare Cause of Lower Gastrointestinal Bleeding: Behcet ’s Disease
(Source: Journal of Gastrointestinal Surgery)
Source: Journal of Gastrointestinal Surgery - March 17, 2023 Category: Surgery Source Type: research
Behcet's disease in a patient with primary sclerosing cholangitis: a case report and literature review
In this report, we present the case of BD in a 56-year-old man with primary sclerosing cholangitis, followed by a literature review covering current insights into BD aetiology, diagnostics and treatment.PMID:36909906 | PMC:PMC9993197 | DOI:10.5114/ada.2022.124678 (Source: Advances in Dermatology and Allergology)
Source: Advances in Dermatology and Allergology - March 13, 2023 Category: Dermatology Authors: Natalia P Bielecka-Kowalska Natalia Lewkowicz Source Type: research
